About this trial

The aim of the present study is to test the accuracy and reliability of AI tools in this regard by interpreting NIRS, which we routinely use for monitoring cerebral perfusion in cardiovascular surgery, with AI tools and comparing this interpretation with the interpretations of two clinicians.

Eligibility criteria

Qualifiers

open cardiac surgery

elective open heart surgery

aged 18-65

ASA score I-III

Disqualifiers

past ischemic event

carotid arter stenosis

BMI >30 kg/m2

serious liver or kidney disease

Trial design

Treatments tested in this trial

  • CHATGPT GROUP
  • GEMINI GROUP
  • COPILOT GROUP
  • CLINICIAN GROUP

Treatment groups

63 Participants
are divided into 4 treatment groups

Locations

1
Antalya Training and Researching hospital AntalyaMuratpaşa, Turkey (Türkiye)

Sponsors and collaborators

Antalya Health Sciences University

Lead sponsor